Collins Helen Louise 4
4 · Enliven Therapeutics, Inc. · Filed Apr 6, 2023
Insider Transaction Report
Form 4
Collins Helen Louise
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2023-04-04+206,000→ 206,000 totalExercise: $22.75Exp: 2033-04-04→ Common Stock (206,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option will vest on February 23, 2024 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date